Lactobacillus rhamnosus GG sustained release
Selected indexed studies
- Milk Fat Globules: 2024 Updates. (Newborn (Clarksville), 2024) [PMID:39474586]
- Chemo-immunotherapeutic potential of Lactobacillus rhamnosus GG and its bioengineering for cancer therapy. (Biomaterials, 2026) [PMID:41237436]
- Oral delivery of sodium alginate/chitosan bilayer microgels loaded with Lactobacillus rhamnosus GG for targeted therapy of ulcerative colitis. (Int J Biol Macromol, 2024) [PMID:39153668]
_Worker-drafted node — pending editorial review._
Connections
Lactobacillus rhamnosus GG sustained release helps
Sources
- Milk Fat Globules: 2024 Updates. (2024) pubmed
- Oral delivery of sodium alginate/chitosan bilayer microgels loaded with Lactobacillus rhamnosus GG for targeted therapy of ulcerative colitis. (2024) pubmed
- Chemo-immunotherapeutic potential of Lactobacillus rhamnosus GG and its bioengineering for cancer therapy. (2026) pubmed
- Microencapsulation of Lacticaseibacillus rhamnosus GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release. (2022) pubmed
- Influence of the pili of Lacticaseibacillus rhamnosus GG on its encapsulation and survival in mixed protein-starch gels assembled by in situ fermentation. (2025) pubmed
- Biopolymer-Based Minimal Formulations Boost Viability and Metabolic Functionality of Probiotics Lactobacillus rhamnosus GG through Gastrointestinal Passage. (2018) pubmed
- pH-sustaining nanostructured hydroxyapatite/alginate composite hydrogel for gastric protection and intestinal release of Lactobacillus rhamnosusGG. (2023) pubmed
- Lactic Acid Production from Acid Hydrolysate of Ulva pertusa as a Sustainable Biomass Feedstock. (2026) pubmed